Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02442011 · ClinicalTrials.gov registry record
Hematology Biobank: In Vitro Study of Blood Disorders
A clinical trial of Hematological Disorders, sponsored by Albert Einstein College of Medicine.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT02442011 is a study of Hematological Disorders that is actively recruiting participants, run by Albert Einstein College of Medicine. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02442011, a study of Hematological Disorders, is actively recruiting participants, sponsored by Albert Einstein College of Medicine.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a biorepository of blood specimens from subjects with different Hematological disorders.
Conditions Studied
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2014-01 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02442011
The ClinicalTrials.gov registry entry for NCT02442011 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hematological Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT02442011 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02442011 about?
NCT02442011 is a clinical study titled "Hematology Biobank: In Vitro Study of Blood Disorders". This is a biorepository of blood specimens from subjects with different Hematological disorders.
What is the current status of trial NCT02442011?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2014-01. Estimated completion is 2030-01.
What conditions does trial NCT02442011 study?
This clinical trial studies the following conditions: Hematological Disorders.
Who is sponsoring clinical trial NCT02442011?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02442011 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.